Your browser doesn't support javascript.
loading
Survival Analysis of 148 Patients with Primary Diffuse Large B Cell Lymphoma / 中国实验血液学杂志
Article de Zh | WPRIM | ID: wpr-774358
Bibliothèque responsable: WPRO
ABSTRACT
OBJECTIVE@#To investigate the clinical outcome of the patients with primary diffuse large B-cell lymphoma(DLBCL).@*METHODS@#Clinical data of 148 patients with DLBCL in our hospital and cancer hospital from March 2006 to April 2016 were retrospectively analyzed. Kaplan-Meier analysis was used to estimate progression-free survival(PFS)and overall survival(OS).@*RESULTS@#5-year OS and PFS rates were 85% and 69%,respectively. The survival analysis showed that 5-year OS rate of R-CHOP group was significantly higher than that of CHOP alone group(89% vs. 70%,P60 years),poor ECOG score(≥2),advanced stage(Ⅲ-Ⅳ),higher IPI score(≥3),CHOP alone and absence of radiotherapy related with poor survival rate. Furthermore,multivariate analysis showed that age>60 year significantly related with the worse OS.@*CONCLUSION@#Age >60 year is an important independent prognostic factor to predict worse OS or PFS.
Sujet(s)
Texte intégral: 1 Indice: WPRIM Sujet Principal: Pronostic / Protocoles de polychimiothérapie antinéoplasique / Doxorubicine / Études rétrospectives / Lymphome B diffus à grandes cellules / Survie sans rechute / Cyclophosphamide / Anticorps monoclonaux d'origine murine Type d'étude: Observational_studies / Prognostic_studies Limites du sujet: Humans langue: Zh Texte intégral: Journal of Experimental Hematology Année: 2019 Type: Article
Texte intégral: 1 Indice: WPRIM Sujet Principal: Pronostic / Protocoles de polychimiothérapie antinéoplasique / Doxorubicine / Études rétrospectives / Lymphome B diffus à grandes cellules / Survie sans rechute / Cyclophosphamide / Anticorps monoclonaux d'origine murine Type d'étude: Observational_studies / Prognostic_studies Limites du sujet: Humans langue: Zh Texte intégral: Journal of Experimental Hematology Année: 2019 Type: Article